Company Filing History:
Years Active: 2014-2015
Title: Gregor McDonald: Innovator in Neurological Treatments
Introduction
Gregor McDonald is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of neuroscience through his innovative research and patented inventions. With a total of 2 patents, McDonald focuses on developing compounds that can aid in treating neurological and psychiatric disorders.
Latest Patents
McDonald's latest patents include "Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulators." This invention relates to substituted 6-methylnicotinamide analogs and derivatives that serve as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). The patent outlines synthetic methods for creating these compounds, pharmaceutical compositions that include them, and methods for treating disorders associated with glutamate dysfunction.
Another significant patent is "Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors." This invention also focuses on compounds that act as positive allosteric modulators of mGluR5. It details synthetic methods for producing these compounds, their pharmaceutical applications, and their potential in treating neurological and psychiatric disorders.
Career Highlights
Gregor McDonald is affiliated with Vanderbilt University, where he continues to advance his research in the field of neuroscience. His work has garnered attention for its potential impact on treating various neurological conditions.
Collaborations
Some of McDonald's notable collaborators include P Jeffrey Conn and Craig William Lindsley. Their combined expertise contributes to the innovative research being conducted at Vanderbilt University.
Conclusion
Gregor McDonald is a prominent inventor whose work in developing allosteric modulators for mGluR5 receptors holds promise for advancing treatments for neurological disorders. His contributions to the field are significant and continue to inspire further research and innovation.